Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
13.30
-0.04 (-0.30%)
Jul 20, 2026, 10:31 AM EDT - Market open
Kazia Therapeutics Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Kazia Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $27.74. The average 1-year stock price forecast is 108.57% higher than the current stock price, while the lowest is $17.55 (+31.95%) and the highest is $34.1 (+156.39%).
Price Target: $27.74 (+108.57%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Kazia Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 3 |
| Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 3 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Buy Maintains $34 | Buy | Maintains | $34 | +155.64% | Jul 16, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $30 | Buy | Reiterates | $30 | +125.56% | Jul 16, 2026 |
| Lake Street | Lake Street | Buy Initiates $32 | Buy | Initiates | $32 | +140.60% | Jun 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $18 | Buy | Reiterates | $18 | +35.34% | Jun 3, 2026 |
| Laidlaw | Laidlaw | Buy Initiates $25 | Buy | Initiates | $25 | +87.97% | Apr 15, 2026 |
Financial Forecast
Revenue This Year
357.00K
from 1.83M
Decreased by -80.48%
Revenue Next Year
145.00K
from 357.00K
Decreased by -59.38%
EPS This Year
-0.05
EPS Next Year
n/a
from -0.05
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.